74例肺结核抗结核组合药疗效及不良反应的临床观察  

The Clinical Observation of 74 cases of Pulmonary TB Combination Drug Efficacy and Adverse Reactions

作　　者：梁成员[1] 

机构地区：[1]广西百色市人民医院感染性疾病科,广西百色533000

出　　处：《中国医药指南》2013年第31期326-326,328,共2页Guide of China Medicine

摘　　要：目的探究肺结核抗结核组合药治疗肺结核疾病的安全性与效果,确定肺结核抗结核组合药的治疗意义。方法以我院病房及门诊收治的74例肺结核病患者为研究对象,平均随机分为2组,每组37例患者,对照组采用传统药物进行治疗,实验组则采用抗结核组合药进行治疗。结果抗结核组合药进行治疗的总有效率为(94.59%),不良反应患者2例。传统药物进行治疗的总有效率为(75.68%),不良反应患者6例。结论使用肺结核抗结核组合药患者的治疗效果好,值得临床推广。Objective To explore tuberculosis TB combination drug safety and effect in the treatment of tuberculosis diseases, determine the combination of anti-tuberculosis drugs for tuberculosis treatment. Methods 74 cases of pulmonary tuberculosis patients in our hospital as the research object, the average were randomly divided into two groups, each group of 37 patients, the control group using traditional Chinese medicine treatment, the experimental group adopts combination of anti-tuberculosis drugs for treatment. Results The combination of anti-tuberculosis medicine treatment the total effective rate was （94.59%）, 2 patients with adverse reactions. Traditional Chinese medicine treatment the total effective rate of （75.68%）, 6 patients with adverse reactions. Conclusion The treatment of patients with using a combination of tuberculosis anti-tuberculosis medicine effect is good, worthy of clinical promotion.

关 键 词：肺结核 抗结核组合药 疗效 不良反应 

分 类 号：R521[医药卫生—内科学]